Catalyst Pharmaceuticals, Inc. (CPRX) Deep Dive Video

Summary

A cash-rich rare-disease compounder priced for a patent cliff—FIRDAPSE legal clarity and oncology-driven LEMS diagnosis are the unlocks while AGAMREE scales.

View CPRX stock page · Read the CPRX research report

Loading the video player…